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Abstract
The aim of this research was to develop a method for noninvasive staging of liver fibrosis (LF) in patients with chronic 
hepatitis C (CHC) based on ultrasound imaging (UI) of the abdominal cavity. 
We examined 124 patients with CHC. The diagnosis was verified on the basis of clinical and epidemiological, serological and 
molecular biological data. Direct ultrasonic parameters of the structure and hemodynamics of liver and spleen were supplemented 
with estimated indicators: square of the expected cross-section of     the lobes of the liver and spleen, as well as their ratio. On the 
basis of the discriminant analysis of the survey data of 82 patients, we developed an analytical model (with predictive value of 
95.2%) for interval estimation of the fibrosis degree in CHC patients. We have concluded that UI performed on modern equipment, 
including Doppler, is able to determine the degree of LF without resorting to histological verification.
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Introduction
Liver fibrosis (LF) is the main pathogenetic mechanism 
of liver damage in HCV infection, and its progression leads 
to liver dysfunction, development of complications, and the 
patient’s death [1]. Evaluation of fibrosis is important for the 
decision to start treatment, predict the disease, and monitor the 
development of the cirrhosis complications [2]. Currently, none 
of the known methods for determining the stage of fibrosis can 
be considered optimal. Despite the extremely high value of 
histological determination of the degree of LF by using needle 
biopsy, this method has a number of drawbacks: the invasive 
nature of the procedure with the potential risk of complications 
and  complexity  of  monitoring  [3,4].  Noninvasive  tests 
(transient elastography and the serum marker FibroTest), all 
widespread in recent years, are expensive and not included 
in  the  national  standard  of  examination;  furthermore, 
their  specificity  is  insufficiently  known  [5].  However,  the 
improvement  of  ultrasound  diagnosis,  the  development  of 
computer technology with improving resolution of scanners, 
and the emergence of new modes of scanning and data 
processing software for echo sounders enhance the diagnostic 
capabilities of UI [5-7].
The aim of this research was to develop a method for 
noninvasive  staging  of  liver  fibrosis  (LF)  in  patients  with 
chronic hepatitis C (CHC) based on ultrasound imaging (UI) 
of the abdominal cavity. 
Material and Methods
The group inpatient and outpatient patients with CHC at 
different stages of the process were examined among patients 
of the Hepatological Regional Center of Samara (Samara State 
Medical University) during 2005–2012. The diagnosis was 
verified according to clinical, epidemiological, biochemical, 
serological  and  molecular-biology  data.  All  patients 
underwent UI of the abdominal cavity and, in the absence of 
contraindications  and  with  patient  consent,  hepatic  biopsy. 
In some cases, to identify the degree of portal hypertension 
and  the  nature  of  co-morbidity,  a  fibrogastroduodenoscopy 
was  made. We  used  the Toshiba  370A  Power  vision  6000 
ultrasound scanner and two multi-frequency probes (3.0-6.0 
MHz convex and linear 6.0-11.0 MHz). Investigation of the 
parameters of hepatic hemodynamics was performed in triplex 
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scanning mode. Insonation angle correction was optimal in all 
cases. A linear probe was used to further assess the state of the 
contour of the liver. Part of the examination was conducted 
by  a  SONOACE  X-8  ultrasound  scanner  using  Dynamic 
MRTM technology, which allows the basic two-dimensional 
image to be represented in real-time with optimal contrast and 
image sharpness, maximizes the visualization of contours and 
boundaries of the tissues with different acoustic density at a 
frequency of 2.5 to 5.0MHz. 
In UI, sound conduction, echogenicity of the liver and 
periportal pattern were evaluated by the rank scale (0 - no 
change, 1 - reinforced, 2 - reduced); echogenicity of the liver 
(0 - no change, 1 - enhanced 2 - reduced) and periportal pattern 
(no change - 0, deformed - 1; stress in the gate of the liver - 2, 
on the periphery - 3, on all fields - 4). Sixteen quantitative 
indicators were also recorded: obliquely-vertical size of the 
right lobe of the liver, cm; the thickness of the right hepatic 
lobe, cm; cross-sectional area of the right hepatic lobe cm2; 
cranio-caudal size of the left lobe, cm; the thickness of the left 
hepatic lobe, cm; cross-sectional area of     the left hepatic lobe, 
cm2; spleen length, mm; spleen thickness mm; cross-sectional 
area of     the spleen, mm2; portal vein diameter, mm; splenic 
vein diameter, mm (at the gate); mesenteric vein diameter, 
mm; blood flow rate in portal vein (cm/sec); sectional area 
ratio of the liver and spleen; cross-section of the right hepatic 
lobe  to the spleen; cross-section of the left hepatic lobe to the 
spleen. 
Histological examination of biopsy samples (obtained 
by liver biopsy) was carried out after fixation in 10% buffered 
formalin and stained with hematoxylin and eosin. A biopsy 
not less than 15 mm and containing at least 3–4 portal tracts 
was considered as informative. Degree of fibrosis on the basis 
of histological examination of liver tissue was determined by 
METAVIR classification. 
The data obtained were subjected to linear discriminant 
analysis using a stepwise algorithm and excluding 
discriminating variables (all ultrasonic indicators), as well as 
gender and age of patients. The purpose of the this analysis 
was  to  build  classification  functions,  allowing    each  new 
observation to be referred to one of the classes, reflecting some 
degree of LF, according to an optimal set of discriminating 
variables.  In  accordance  with  the  specified  algorithm,  in 
the first stage of analysis, all variables were included in the 
discriminant model (DM), and then at each step, variables, 
having a small contribution to the task of fibrosis diagnosis, 
were eliminated. As a determining factor for the inclusion 
or  exclusion  of  variables  from  the  model,  values  of  the 
corresponding  F-statistics  were  used.  In  addition  to  the 
F-statistics of each variable, at each step of the algorithm such 
indicators as λ of DM as a whole, λ of each variable of  DM, 
λ private statistics of each variable of the model, F-statistics 
of DM as a whole, and tolerance of each variable of DM were 
evaluated. Mathematical and statistical analysis of data was 
performed using the STATISTISA 6.0. 
A total of 124 CHC patients were examined according to 
the specified program. Data of 82 patients were used to build 
DM, and data of the remaining 42 patients were used to test 
the accuracy of DM. 
Result and Discussion
The analysis showed that the most appropriate in terms 
of determining the degree of LF is DM, which includes the 
following  discriminating  variables:  gender;  length,  width 
and  cross-sectional  area  of  the  spleen,  liver  echogenicity 
and sound conduction, the diameter of the portal vein, the 
nature of periportal pattern, and the average velocity of portal 
blood flow. The model as a whole was statistically significant 
(λ=0.887; F = 9.819, P <0.00001). Other quality evaluation of 
DM is shown in Table 1. 
The  developed  DM  contained  the  four  functions  of 
classification of fibrosis stages:
КF0 = -5272.10 + 51.77х1 + 103.79х2 + 255.72х3 – 2.33х4 – 
-73.36х5 – 37.83х6 – 35.79х7 – 59.89х8 – 8.37х9;
КF1 = -5430.39 + 56.27х1 + 105.43х2 + 259.97х3 – 2.37х4 – 
-74.73х5 – 37.71х6 – 36.13х7 – 64.64х8 – 9.65х9;
КF2 = -5381.91 + 55.44х1 + 104.72х2 + 258.66х3 – 2.35х4 – 
-71.78х5 – 34.36х6 – 33.63х7 – 69.12х8 – 10.34х9;
КF3 = -5365.65 + 56.55х1 + 104.50х2 + 257.58х3 – 2.34х4 – 
-73.28х5 – 33.20х6 – 33.42х7 – 70.44х8 – 10.68х9,
where KF0 - zero value of the classification stage of fibrosis; 
KF1 - value of the first classification stage of fibrosis; KF2 - 
value of the second classification stage of fibrosis; KF3 - value 
of the third classification stage of fibrosis; x1 - gender, points 
(pts); x2 - the length of the spleen, mm; x3 - the width of the 
spleen, mm; x4 - cross-section of the spleen, mm; x5 - liver 
sound conduction pts; x6 - liver echogenicity pts; x7 - portal 
vein diameter, mm; x8 - periportal pattern, pts; x9 - average 
speed of blood flow in the portal vein, cm/s. 
The desired stage of LF corresponded to the index of 
function  of  classification  with  the  highest  value.  Practical 
application  of  the  developed  method  for  noninvasive 
determination of the degree of LF in СHС patients is shown in 
the following clinical examples.
 Table 1. 
Variables of the DM for noninvasive determination of the LF degree 
in patients with CHC
Discriminating 
variable
Wilks’ λ Partial λ F p Tolerance
Gender 0.104 0.852 4.068 0.010 0.665
Spleen length 0.111 0.800 5.818 0.001 0.017
Spleen width 0.114 0.781 6.556 0.001 0.012
Cross section of 
the spleen 0.113 0.784 6.420 0.001 0.005
Sound conduction 
of the liver 0.107 0.827 4.894 0.004 0.601
Echogenicity of 
the liver 0.100 0.887 2.961 0.038 0.687
Portal vein 
diameter 0.127 0.698 10.083 0.000 0.467
Periportal pattern 0.149 0.595 15.909 0.000 0.261
Average speed of 
portal blood flow 0.178 0.499 23.412 0.000 0.517177  D. Konstantinov et al / International Journal of BioMedicine 4(3) (2014) 175-178
Example 1.  In male patients with CHC the following 
parameters of the abdominal cavity UI were identified: spleen 
length - 98 mm, the width of the spleen - 44 mm, cross-section 
of the spleen – 4,312 mm, sound conduction of the liver – 0 
pts, the echogenicity of the liver -2 pts, the diameter of the 
portal vein -13.7 mm, the periportal pattern – 2 pts, and the 
average speed of blood flow in the portal vein -14.4 cm/s. 
The  values      of  the  functions  of  the  classification  of 
fibrosis stages were as follows:
КF0  =  -5272.10  +  51.77·1  +  103.79·98  +  255.72·44  – 
2.33·4312  –  -73.36·0  –  37.83·2  –  35.79·13.7  –  59.89·2  – 
8.37·14.4 = 5345.04;
КF1  =  -5430.39  +  56.27·1  +  105.43·98  +  259.97·44  – 
2.37·4312  –  -74.73·0  –  37.71·2  –  36.13·13.7  –  64.64·2  – 
9.65·14.4 = 5347.33;
КF2  =  -5381.91  +  55.44·1  +  104.72·98  +  258.66·44  – 
2.35·4312  –  -71.78·0  –  34.36·2  –  33.63·13.7  –  69.12·2  – 
10.34·14.4 = 5350.17;
КF3  =  -5365.65  +  56.55·1  +  104.50·98  +  257.58·44  – 
2.34·4312  –  -73.28·0  –  33.20·2  –  33.42·13.7  –  70.44·2  – 
10.68·14.4 = 5,348.32.
Among the calculated classification functions, the value 
function KF2=5350.17 is the highest, which corresponds to 
the stage of fibrosis, expressed as 2 points. In this patient, the 
stage of LF, according to the morphological study of liver 
biopsies, was also 2 points.
Example 2. In female patient with CHC the following 
parameters of the abdominal cavity UI were identified: spleen 
length - 99 mm, the width of the spleen - 35 mm, cross-section 
of the spleen – 3,465 mm, sound conduction of the liver - 
0 pts, the echogenicity of the liver - 1 pts, the diameter of 
the portal vein - 12.1 mm, periportal pattern - 0 pts, and the 
average speed of blood flow in the portal vein - 24.7 cm/s. 
The  values      of  the  functions  of  the  classification  of 
fibrosis stages were as follows:
КF0  =  -5272.10  +  51.77·0  +  103.79·99  +  255.72·35  – 
2.33·3465  –  -73.36·0  –  37.83·1  –  35.79·12.1  –  59.89·0  – 
8.37·24.7 = 5198.66;
КF1  =  -5430.39  +  56.27·0  +  105.43·99  +  259.97·35  – 
2.37·3465  –  -74.73·0  –  37.71·1  –  36.13·12.1  –  64.64·0  – 
9.65·24.7 = 5187.80;
КF2  =  -5381.91  +  55.44·0  +  104.72·99  +  258.66·35  – 
2.35·3465  –  -71.78·0  –  34.36·1  –  33.63·12.1  –  69.12·0  – 
10.34·24.7 = 5185.27;
КF3  =  -5365.65  +  56.55·0  +  104.50·99  +  257.58·35  – 
2.34·3465  –  -73.28·0  –  33.20·1  –  33.42·12.1  –  70.44·0  – 
10.68·24.7 = 5179.29.
Among the calculated classification functions, the value 
function KF0=5,198.66 is the highest, which corresponds to 
the stage of fibrosis, expressed as 0 points. In this patient, the 
stage of LF, according to the morphological study of liver 
biopsies, was also 0 points.
In  order  to  determine  the  diagnostic  significance  of 
the  obtained  classifying  functions,  testing  the  accuracy  of 
noninvasive staging of LF was carried out. To do this, in 42 
CHC  patients,  LF  was  determined  in  two  ways:  test  with 
our  model,  and  histological  examination  of  liver  biopsy, 
which served as the “gold standard.” The test results and the 
final point and interval estimates of baseline parameters of 
diagnostic significance are shown in Tables 2–3.
Table 3 shows that the point estimates of the prognostic 
value of diagnostics of the various stages of LF are unequal 
and  relatively  small  (35.3-72.2%).  However,  the  analysis 
of residues of DM showed that the degree of fibrosis was 
determined  accurately  in  57.1%  of  cases.  A  deviation  of 
the prognostic evaluations from the true values of LF (not 
more than one stage) was observed in 38.1% of the cases. 
Diagnostic errors equal to two stages occurred in only two 
cases  (4.8%):  in  one  case,  it  was  an  overstatement  of  the 
stage; and in another case, it was a lower degree of fibrosis. 
The small size and symmetry of the possible deviations of 
the prognostic estimates with respect to zero determines how 
expedient the practical application of the developed method 
is for noninvasive staging of LF in CHC patients, provided 
the formulation of the final result with its possible diagnostic 
errors, equal to 1 stage, namely, the predictive stage of fibrosis 
± 1 stage. In interval estimation of the degree of fibrosis, the 
predictive value of diagnosis with 95% statistical reliability is 
within 83.8%–99.4%. 
Thus,  ultrasound,  performed  on  modern  equipment, 
Table 3. 
The  point  and  95%  interval  estimates  of  baseline  parameters  of 
diagnostic significance of DM for noninvasive determination of the 
LF degree in patients with CHC
Indicator of diagnostic 
significance  
Histological stage of LF
0 1 2 3
Sensitivity
0.607
1.000
-
-
0
0.171
0.595
0.867
0.983
0.549
1.000
-
Specificity
0.519
0.694
0.837
0.891
1.000
-
0.642
0.815
0.942
0.818
0.946
0.993
Predictive
value
0.142
0.353
0.617
-
-
-
0.465
0.722
0.903
0.290
0.714
0.963
Table 2 .
  Quality evaluation of DM for noninvasive determination of the LF 
degree in patients with CHC
Noninvasive 
evaluation
Histological stage of LF
Total
0 1 2 3
0 6 (100%) 10 (62.5%) 1 (6.7%) 0 17
1 0 0 0 0 0
2 0 5 (31.3%) 13 (86.7%) 0 18
3 0 1 (6.3%) 1 (6.7%) 5 (100%) 7
Total 6 (100%) 16 (100%) 15 (100%) 5 (100%) 42178                                       D. Konstantinov et al / International Journal of BioMedicine 4(3) (2014) 175-178
allows to determine the degree of liver fibrosis of patients with 
chronic hepatitis C without resorting to histological diagnosis 
with predictive value 95.2%.
Competing interests
The authors declare that they have no competing interests.
References
1.  Dienstag JL. The role of liver biopsy in chronic hepatitis 
C. Hepatology 2002; 36 (5 Suppl 1):S152-60.
2.   Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes 
D, Easley K. The role of liver biopsy in chronic hepatitis C. 
Hepatology 2001; 33(1):196-200.
3.   Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, 
Chander  G,  Ghanem  KG,  et  al.  Role  of  liver  biopsy  in 
management  of  chronic  hepatitis  C:  a  systematic  review. 
Hepatology 2002; 36(5 Suppl 1):S161-72.
4.  Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, 
Ghany  MG,  et  al.  Complication  rate  of  percutaneous  liver 
biopsies among persons with advanced chronic liver disease in the 
HALT-C trial. Clin Gastroenterol Hepatol 2010; 8(10):877-83.
5.  Smith JO, Sterling RK. Systematic review: non-invasive 
methods of fibrosis analysis in chronic hepatitis C. Aliment 
Pharmacol Ther 2009; 30(6):557-76.
6.   Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, 
et al. Performance of the aspartate aminotransferase-to-platelet 
ratio index for the staging of hepatitis С-related fibrosis: an 
updated meta-analysis. Hepatology 2011; 53(3):726-36.
7.   Klibansky DA, Mehta SH, Curry M, Nasser I, Challies 
T, Afdhal NH. Transient elastography for predicting clinical 
outcomes in patients with chronic liver disease. J Viral Hepat 
2012; 19(2):e184-93.